Wednesday, October 10, 2012

BMGF Grand Challenges Explorations Round 10 Now Open

Grand Challenges Explorations Round 10 Now Open


Deadline: 7 November 2012


Open to All Disciplines: Anyone Can Apply

The grant program is open to anyone from any discipline, from student to tenured professor, and from any organization – colleges and universities, government laboratories, research institutions, non-profit organizations and for-profit companies.

Agile, Accelerated Grant-Making

The initiative uses an agile, accelerated grant-making process with short two-page applications and no preliminary data required. Applications are submitted online, and winning grants are chosen approximately 4 months from the submission deadline. Initial grants of $100,000 are awarded two times a year. Successful projects have the opportunity to receive a follow-on grant of up to $1 million.


Application Instructions

Step 1: Read the Details
To get started, download and read the Rules and Guidelines document (PDF) . It contains detailed information on all aspects of Grand Challenges Explorations. You may need to download Adobe Reader to view PDF documents. Please also read the Terms and Conditions, and Privacy Policy. Any information submitted by you or on your behalf with respect to the Grand Challenges Explorations Initiative (including your proposal, reports, and any related documentation and communications) will be subject to and handled in accordance with the provisions in these three documents. Changes to the rules and guidelines will be posted on the Frequently Asked Questions page of this Web site. Please read the current FAQs before submitting any questions or concerns.

Step 2: Read The Topics


Topics are presented for each Grand Challenges Explorations round. Read the detailed information about GCE Topics on the Topics Overview page and then read the Topic Descriptions for this round to determine which topic best suits your idea.

Step 3: Download the Application Form


Please download the Application Form for specific instructions on the format and content of your application. Please note that some users may see a screen asking them to log in when opening the Application Form. This is an issue with some versions of Microsoft Office. Click Cancel and the Application Form will open for you. All proposals must be written in English.
Step 4: Create an Account, Register for a Topic, and Submit your ProposalYou may create an account using our online Explorations Application Tool.  This tool will enable you to register for an Explorations topic as well as create, edit, or submit your proposal.  After you have created an account and registered for a topic, you can start the online application process. All applications must be submitted through this online system.

Tips for Grant Seekers


Following are some tips for grant seekers wishing to submit proposals:

  • Proposals must represent an innovative approach responsive to the topic.  There are other avenues of funding for the equally important research that is within currently accepted paradigms.  Such work will not be funded under Grand Challenges Explorations. 
  • Proposals will be reviewed by a panel with broad expertise and a track record in identifying innovations – these reviewers may not be deep domain experts in your field.  Ideas should be described in clear language without the use of jargon unique to a particular field (see How Grants are Selected).
  • Proof-of-concept for ideas need not be completed in Phase I. However, credible evidence supporting the validity of an idea, sufficient proof to warrant expanded support, and next steps for the project should be provided.
For assistance, advice, and further information
Please contact us at the Office of Research Services
 We will be delighted to help you with your application

or phone us on ext 1332

Friday, October 5, 2012

NIH Grant: Immunity in the Elderly (R01) (RFA-AI-12-038)

Immunity in the Elderly

The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Aging (NIA) invite applications to define the mechanisms for induction, development, and maintenance of protective immunity in the elderly in response to infections with or vaccinations against NIAID Emerging and Re-emerging Infectious Diseases

  The goal of this FOA is to develop a better understanding of the immune mechanisms involved during the aging process that contribute to impaired immune responses resulting in severe infections and dampened responses to vaccines in this population.  This FOA requires human studies, to gain insights into immune changes in elderly individuals.  Thus, at least one aim of the project must focus fully on human studies; appropriately justified animal work may be included in additional aims to conduct mechanistic studies that are not possible in humans. 

Funding Opportunity Announcement (FOA) Number
RFA-AI-12-038
Open Date (Earliest Submission Date)
January 18, 2013  
Letter of Intent Due Date
January 18, 2013  
Application Due Date(s)
February 20, 2013
Funds Available and Anticipated Number of Awards
The following NIH components intend to commit the following amounts in FY2014:

NIAID, $4 million, 8-10 awards
NIA, $2 million, 4-5 awards   
Award Budget
Direct costs for each application are expected to be $300,000 or less per year, plus appropriate F&A costs. Budgets should be commensurate with the proposed studies and adequately justified.  
Award Project Period
Scope of the proposed project should determine the project period.  The maximum period is 5 years. 

The original announcement and further details are available at:

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-038.html

Wednesday, October 3, 2012

REMINDER: TDR Clinical Research & Development Fellowships



REMINDER!


Applications must be received by 7th October 2012


Researchers from low and middle income countries (LMICs) are invited to apply for the fourth round of the WHO/TDR Career Development Fellowship (CDF) on clinical research & development (clinical R&D). Successful candidates will be placed with leading product development institutions, including pharmaceutical companies that are participating in the fellowship programme (“host institutions”). The goal is to develop human resources to promote high quality clinical R&D in LMICs. It is expected that qualified professionals will enhance LMICs’ product development capacity on diagnostics, drugs and vaccines for infectious diseases that disproportionately affect poor and marginalized populations.
The host institutions will train individuals in situ in order to develop specialized skills not readily taught in academic centres, including R&D project management, regulatory requirements and good health research practices. On returning to their home institutions, the fellows are expected to become an important resource for institutional capacity development to undertake and manage clinical research in accordance with international regulatory requirements and standards.